Jul 25, 2019 8:00am EDT Pieris Pharmaceuticals To Host Second Quarter 2019 Investor Call And Corporate Update On August 1, 2019
May 30, 2019 8:00am EDT Pieris Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
May 22, 2019 2:30pm EDT Pieris Pharmaceuticals and AstraZeneca Present Single- Ascending Dose Phase 1a Data for Inhaled IL-4Rα Antagonist AZD1402/PRS-060 at the American Thoracic Society (ATS) 2019 International Conference
May 14, 2019 8:00am EDT Pieris Pharmaceuticals to Present at the 2019 RBC Capital Markets Global Healthcare Conference
May 10, 2019 7:00am EDT Pieris Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
May 03, 2019 8:00am EDT Pieris Pharmaceuticals to Host First Quarter 2019 Investor Call and Corporate Update on May 10, 2019
Apr 03, 2019 8:50am EDT Pieris Pharmaceuticals to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
Apr 02, 2019 8:00am EDT Pieris Pharmaceuticals Presents Preclinical Data for GPC3/4-1BB Bispecific PRS-342 at the 2019 American Association for Cancer Research (AACR) Annual Meeting
Mar 12, 2019 7:00am EDT Pieris Pharmaceuticals Reports 2018 Year-End Cash Position and Provides Corporate Update
Mar 06, 2019 8:00am EST Pieris Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference
